References
- SEER Cancer Statistics Review 1973–1992. Tables and graphs, C L Kosary, L AG Ries, A B Miller, B F Hankey, A Harras, B K Edwards. National Cancer Institute, Bethesda, MDUSA, NIH Publications No. 96–2789
- Kallioniemi O-P, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996; 68: 226–55
- Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995; 83: 851–7
- Brinkmann A O, Jenster G, Kuiper G GJM, Ris C, van der Korput J AGM, Degenhart H J, Trifiro M A, Pinsky L, Romalo G, Schweikert H U, Veldscholte J, Mulder E, Trapman J. The human androgen receptor: Structure/function relationship in normal and pathological situations. J Steroid Biochem Molec Biol 1992; 41: 361–8
- Young CY-F, Andrews P E, Montgomery B T, Tindall D J. Tissue specific and hormonal regulation of human prostate specific glandular kallikrein. Biochemistry 1992; 31: 818–24
- Perry J E, Tindall D J. Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res 1996; 56: 1539–44
- Culig Z, Hobisch A, Cronauer M V, Cato A C, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 1993; 7: 1541–50
- Taplin M E, Bubley G J, Shuster T D, Frantz M E, Spooner A E, Ogata G K, Keer H N, Balk S P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393–8
- Newmark J R, Hardy D O, Tonb D C, Carter B S, Epstein J I, Isaacs W B, Brown T R, Barrack E R. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA 1992; 89: 6319–23
- Ruizeveld de Winter J A, Janssen P J, Sleddens H M, Verleun-Mooijman M C, Trapman J, Brinkmann A O, Santerse A B, Schroder F H, van der Kwast T H. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994; 144: 735–46
- Gaddipati J P, Mc Leod D G, Heidenberg H B, Sesterhenn I A, Finger M J, Moul J W, Srivastava S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 1994; 54: 2861–4
- Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J. Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Molec Biol 1993; 46: 759–65
- Visakorpi T, Kallioniemi A H, Syvänen A-C, Hyytinen E, Karhu R, Tammela T, Isola J, Kallioniemi O-P. Gains and losses of DNA sequences in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995a; 55: 342–7
- Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray J W, Waldman F M, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818–21
- Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith H S, Waldman F M, Pinkel D, Gray J W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1992; 89: 5321–5
- Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi O-P, Isola J. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994; 16: 93–9
- Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 1995; 9: 401–6
- Göker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E, Bertino J R. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoplastic leukemia and is correlated with p53 gene mutations. Blood 1995; 86: 677–84
- Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi O-P. Androgen receptor gene amplification: A possible molecular mechanism for failure of androgen deprivation therapy in prostate cancer. 1996, Submitted for publication